Watch Ticker

Oncolytics Biotech, Inc. Common Shares

Go to Oncolytics Biotech, Inc. Common Shares Website

$0.89

-0.10 (-10.40%)

Live

Previous Close

$0.99

Day Range

$0.8 - $0.99

Previous Day Range

$0.9502 - $1.04

Market Cap

$95.6 million USD

Day Vol.

977952

Previous Day Vol.

537833

Currency

USD

Primary Exchange

Nasdaq

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelar...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments

Several biotech companies are developing innovative cancer treatments, with promising clinical trial results in various cancer types, focusing on immunotherapy and personalized medicine approaches.

Related tickers: ONCY, CELC, LYEL, EVAX, AGEN.

Read Full Article

Prnewswire - High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds

Despite regulatory challenges and budget cuts, the oncology market is projected to reach US$900 billion by 2034, with several biotech companies advancing innovative cancer therapies and demonstrating promising clinical trial results.

Related tickers: ONCY, CUE, VSTM, ALLO, CATX.

Read Full Article

Trending Tickers

Please sign in to view